Cuervo Guillermo, Rombauts Alexander, Caballero Queralt, Grau Immaculada, Pujol Miquel, Ardanuy Carmen, Berbel Dámaris, Gudiol Carlota, Sánchez-Salado Jose Carlos, Ruiz-Majoral Alejandro, Sbraga Fabrizio, Gracia-Sánchez Laura, Peña Carmen, Carratalà Jordi
Department of Infectious Diseases, Hospital Universitari de Bellvitge, IDIBELL (Institut d'Investigació Biomèdica de Bellvitge), University of Barcelona, Barcelona, Spain.
CIBER de Enfermedades Respiratorias, ISCIII, Madrid, Spain.
Open Forum Infect Dis. 2018 Jul 27;5(8):ofy183. doi: 10.1093/ofid/ofy183. eCollection 2018 Aug.
The purpose of this study was to analyze the secular trends of infective endocarditis in a teaching hospital between January 1996 and December 2015.
We report on a single-center retrospective study of patients with left-side valve infective endocarditis. We performed an analysis of secular trends in the main epidemiological and etiological aspects, as well as clinical outcomes, in 5 successive 4-year periods (P1 to P5).
In total, 595 episodes of infective endocarditis were included, of which 76% were community-acquired and 31.3% involved prosthetic valves. Among the cases, 70% occurred in men, and the mean age (SD) was 64.1 (14.3) years. A significant increase in older patients (age ≥70 years) between P1 (15.332%) and P5 (51.9%; < .001) was observed. The rate of infective endocarditis on biological prostheses also increased in the prosthetic group, accounting for 30% in P1 and 67.3% in P5 ( < .001). By contrast, there were significant decreases in vascular and immunological phenomena over the study period, with decreases in the presence of moderate to severe valvular insufficiency (75.9% in P1 to 52.6% in P5; < .001) and valvular surgery (43% in P1 vs 29.6% in P5; = .006). Finally, overall mortality was 23.9%, and although it was highest in P1, it subsequently remained stable through P2 to P5 (38% in P1 to 20% in P5; = .004).
There has been a significant increase in infective endocarditis in older patients. The decrease in moderate to severe valve regurgitation at diagnosis could explain the stable mortality despite the increase in the mean age of patients over time.
本研究旨在分析1996年1月至2015年12月期间一家教学医院感染性心内膜炎的长期趋势。
我们报告了一项关于左侧瓣膜感染性心内膜炎患者的单中心回顾性研究。我们对连续5个4年时间段(P1至P5)内主要流行病学和病因学方面以及临床结局的长期趋势进行了分析。
总共纳入了595例感染性心内膜炎发作病例,其中76%为社区获得性感染,31.3%累及人工瓣膜。在这些病例中,70%发生在男性,平均年龄(标准差)为64.1(14.3)岁。观察到P1(15.332%)至P5(51.9%;P<0.001)期间老年患者(年龄≥70岁)显著增加。人工瓣膜组中生物瓣感染性心内膜炎的发生率也有所增加,P1时占30%,P5时占67.3%(P<0.001)。相比之下,在研究期间血管和免疫现象显著减少,中度至重度瓣膜关闭不全的发生率降低(P1时为75.9%,P5时为52.6%;P<0.001),瓣膜手术发生率也降低(P1时为43%,P5时为29.6%;P=0.006)。最后,总体死亡率为23.9%,虽然在P1时最高,但随后在P2至P5期间保持稳定(P1时为38%,P5时为20%;P=0.004)。
老年患者感染性心内膜炎显著增加。诊断时中度至重度瓣膜反流的减少可以解释尽管患者平均年龄随时间增加但死亡率仍保持稳定的原因。